HROW
Harrow Health Inc

3,385
Mkt Cap
$1.27B
Volume
1.18M
52W High
$54.85
52W Low
$20.85
PE Ratio
-208.56
HROW Fundamentals
Price
$34.10
Prev Close
$35.56
Open
$35.80
50D MA
$46.30
Beta
1.45
Avg. Volume
551,403.15
EPS (Annual)
-$0.1398
P/B
24.21
Rev/Employee
$730,034.85
$1,979.96
Loading...
Loading...
News
all
press releases
HC Wainwright Issues Negative Forecast for Harrow Earnings
Harrow, Inc. (NASDAQ:HROW - Free Report) - Equities research analysts at HC Wainwright reduced their Q1 2026 earnings per share estimates for Harrow in a report issued on Wednesday, March 4th. HC...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
HC Wainwright Has Pessimistic Outlook of Harrow Q3 Earnings
Harrow, Inc. (NASDAQ:HROW - Free Report) - Equities researchers at HC Wainwright decreased their Q3 2026 earnings per share (EPS) estimates for shares of Harrow in a research note issued to investors...
MarketBeat·9d ago
News Placeholder
Harrow (NASDAQ:HROW) Rating Lowered to "Strong Sell" at Zacks Research
Zacks Research lowered Harrow from a "hold" rating to a "strong sell" rating in a report on Tuesday...
MarketBeat·9d ago
News Placeholder
Cantor Fitzgerald Lowers Harrow (NASDAQ:HROW) Price Target to $91.00
Cantor Fitzgerald lowered their price target on shares of Harrow from $94.00 to $91.00 and set an "overweight" rating for the company in a research report on Wednesday...
MarketBeat·10d ago
News Placeholder
Harrow (NASDAQ:HROW) Stock Price Expected to Rise, HC Wainwright Analyst Says
HC Wainwright boosted their price objective on Harrow from $69.00 to $70.00 and gave the stock a "buy" rating in a research note on Wednesday...
MarketBeat·10d ago
News Placeholder
Harrow Q4 Earnings Call Highlights
Harrow (NASDAQ:HROW) executives used the company's fourth-quarter 2025 earnings call to highlight what CEO Mark Baum described as a five-year transformation into a diversified ophthalmic platform...
MarketBeat·11d ago
News Placeholder
Harrow (NASDAQ:HROW) Shares Gap Down After Earnings Miss
Harrow (NASDAQ:HROW) Shares Gap Down on Disappointing Earnings...
MarketBeat·11d ago
News Placeholder
Harrow (HROW) Misses Q4 Earnings Estimates
Harrow (HROW) delivered earnings and revenue surprises of -34.46% and +0.33%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·12d ago
News Placeholder
Harrow, Inc. $HROW Shares Sold by Royce & Associates LP
Royce & Associates LP cut its stake in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 3.7% during the third quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·12d ago
News Placeholder
88,855 Shares in Harrow, Inc. $HROW Bought by Lumbard & Kellner LLC
Lumbard & Kellner LLC acquired a new position in Harrow, Inc. (NASDAQ:HROW - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities...
MarketBeat·12d ago
<
1
2
...
>

Latest HROW News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.